Yagi S, Iida T, Hori T, Taniguchi K, Nagahama M, Isaji S, Uemoto S
Department of Hepatobiliary, Pancreas and Transplant Surgery, Kyoto University Graduate School of Medicine, Kyoto City, Japan.
Eur Surg Res. 2012;48(3):163-70. doi: 10.1159/000338622. Epub 2012 May 25.
After small-for-size graft (SFSG) transplantation, elevated portal venous pressure (PVP) may lead to postoperative liver damage. Herein we evaluated the impact of portocaval shunt (PCS) to control PVP on liver grafts and intestine following SFSG transplantation.
Nineteen SFSG transplantations were performed with 30% of native liver in swine. Swine were divided into 3 groups: a high-flow shunt group (HS: n = 7), in which portal venous flow (PVF) was reduced with a 10-mm diameter PCS; a low-flow shunt group (LS: n = 6), in which PVF was reduced with a 5-mm diameter PCS, and a no-shunt group (NS: n = 6), in which no PCS was placed.
Seven-day survivals were 83.3% in NS, 100% in LS and 0% in HS (p = 0.0088). PVP was significantly higher in the NS group (p = 0.0001; mean ± SEM NS/LS/HS: 20.5 ± 0.7/14.0 ± 1.2/11.6 ± 0.5 mm Hg). The LS group exhibited the highest compliance (PVF/PVP; NS/LS/HS 42.7 ± 10.9/44.6 ± 4.9/37.7 ± 8.3 ml/min/mm Hg; p = 0.009), the lowest aspartate aminotransferase (NS/LS/HS 562 ± 18/370 ± 55/720 ± 130 IU/l; p = 0.0493), and suppressed deleterious alternations of the hepatic parenchyma and intestinal mucosa.
Portal hypertension after SFSG transplantation impaired liver and intestinal mucosa; however, inadequate portal flow impaired not only the liver, but also survival.
小体积移植物(SFSG)移植后,门静脉压力(PVP)升高可能导致术后肝损伤。在此,我们评估了门腔分流术(PCS)控制PVP对SFSG移植后肝移植物和肠道的影响。
对猪进行19例SFSG移植,移植物为30%的自体肝。猪被分为3组:高流量分流组(HS:n = 7),采用直径10 mm的PCS降低门静脉血流(PVF);低流量分流组(LS:n = 6),采用直径5 mm的PCS降低PVF;无分流组(NS:n = 6),未放置PCS。
NS组7天生存率为83.3%,LS组为100%,HS组为0%(p = 0.0088)。NS组的PVP显著更高(p = 0.0001;NS/LS/HS组均值±标准误:20.5±0.7/14.0±1.2/11.6±0.5 mmHg)。LS组表现出最高的顺应性(PVF/PVP;NS/LS/HS组:42.7±10.9/44.6±4.9/37.7±8.3 ml/min/mmHg;p = 0.009),最低的天冬氨酸转氨酶水平(NS/LS/HS组:562±18/370±55/720±130 IU/l;p = 0.0493),并抑制了肝实质和肠黏膜的有害改变。
SFSG移植后的门静脉高压损害肝和肠黏膜;然而,门静脉血流不足不仅损害肝脏,还影响生存。